Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ruschin

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Journal of Neuro-Oncology|July 16, 2025
Prognostic factors for local failure and overall survival in patients with epidural disease at the cauda equina following stereotactic body radiotherapy: a clinical, anatomic and dosimetric analysisSondos Zayed, Mark Ruschin, Eshetu G Atenafu, et al.
Scientific Reports|December 29, 2019
Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain MetastasisElham Karami, Hany Soliman, Mark Ruschin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain MetastasesSalman Faruqi, Mark Ruschin, Hany Soliman, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2021
Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment ResponseSten Myrehaug, John Hudson, Hany Soliman, et al.
Neurosurgery|June 8, 2019
Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain MetastasesHany Soliman, Sten Myrehaug, Chia-Lin Tseng, et al.
Neuro-Oncology|March 4, 2024
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizonChia-Lin Tseng, K Liang Zeng, Eric A Mellon, et al.
Journal of Neuro-Oncology|August 23, 2022
Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volumeMichael Yan, Lori Holden, Michael Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily FractionsK Liang Zeng, Ahmed Abugarib, Hany Soliman, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain MetastasesHany Soliman, Mark Ruschin, Lilyana Angelov, et al.
Clinical and Translational Radiation Oncology|January 26, 2023
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapyJames Stewart, Arjun Sahgal, Mahtab M Zadeh, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Journal of Neuro-Oncology|July 16, 2025
Prognostic factors for local failure and overall survival in patients with epidural disease at the cauda equina following stereotactic body radiotherapy: a clinical, anatomic and dosimetric analysisSondos Zayed, Mark Ruschin, Eshetu G Atenafu, et al.
Scientific Reports|December 29, 2019
Quantitative MRI Biomarkers of Stereotactic Radiotherapy Outcome in Brain MetastasisElham Karami, Hany Soliman, Mark Ruschin, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2020
Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain MetastasesSalman Faruqi, Mark Ruschin, Hany Soliman, et al.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2021
Hypofractionated Stereotactic Radiation Therapy for Intact Brain Metastases in 5 Daily Fractions: Effect of Dose on Treatment ResponseSten Myrehaug, John Hudson, Hany Soliman, et al.
Neurosurgery|June 8, 2019
Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain MetastasesHany Soliman, Sten Myrehaug, Chia-Lin Tseng, et al.
Neuro-Oncology|March 4, 2024
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizonChia-Lin Tseng, K Liang Zeng, Eric A Mellon, et al.
Journal of Neuro-Oncology|August 23, 2022
Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volumeMichael Yan, Lori Holden, Michael Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2022
Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily FractionsK Liang Zeng, Ahmed Abugarib, Hany Soliman, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain MetastasesHany Soliman, Mark Ruschin, Lilyana Angelov, et al.
Clinical and Translational Radiation Oncology|January 26, 2023
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapyJames Stewart, Arjun Sahgal, Mahtab M Zadeh, et al.
Pageof 11